Asarfi Hospital Ltd — Important, 09-02-2026: Company Update

Asarfi Hospital has shared its Investor Presentation for the quarter ended December 2025. The company posted a 40% year-on-year revenue growth to 46.06 Cr. EBITDA increased 45% to 10.12 Cr, with a 22% margin, while profit after tax more than doubled, rising 102% to 5.48 Cr, reflecting a 12% margin. The Super-Specialty unit reported an ARPOB of ₹24,293 and the Cancer Hospital an ARPOB of ₹43,240. Significant investments are underway to upgrade nuclear imaging and interventional cardiology capabilities, projected for completion by March 2026.